183 related articles for article (PubMed ID: 34044113)
1. Intra-arterial chemotherapy for retinoblastoma in 341 consecutive eyes (1,292 infusions): comparative analysis of outcomes based on patient age, race, and sex.
Shields CL; Dockery PW; Yaghy A; Duffner ER; Levin HJ; Taylor OS; Sajjadi Z; Lally SE; Shields JA; Rosenwasser R; Tjoumakaris S; Jabbour P
J AAPOS; 2021 Jun; 25(3):150.e1-150.e9. PubMed ID: 34044113
[TBL] [Abstract][Full Text] [Related]
2. Rescue intra-arterial chemotherapy following retinoblastoma recurrence after initial intra-arterial chemotherapy.
Shields CL; Say EA; Pointdujour-Lim R; Cao C; Jabbour PM; Shields JA
J Fr Ophtalmol; 2015 Jun; 38(6):542-9. PubMed ID: 25982423
[TBL] [Abstract][Full Text] [Related]
3. Intra-arterial chemotherapy for retinoblastoma in 70 eyes: outcomes based on the international classification of retinoblastoma.
Shields CL; Manjandavida FP; Lally SE; Pieretti G; Arepalli SA; Caywood EH; Jabbour P; Shields JA
Ophthalmology; 2014 Jul; 121(7):1453-60. PubMed ID: 24656794
[TBL] [Abstract][Full Text] [Related]
4. Intra-arterial chemotherapy in refractory and advanced intraocular retinoblastoma.
Kumari N; Jain N; Saboo S; Parthasarathy R; Gupta V; Mahajan A; Das S
Indian J Ophthalmol; 2023 Feb; 71(2):436-443. PubMed ID: 36727336
[TBL] [Abstract][Full Text] [Related]
5. Minimal exposure (one or two cycles) of intra-arterial chemotherapy in the management of retinoblastoma.
Shields CL; Kaliki S; Shah SU; Bianciotto CG; Liu D; Jabbour P; Griffin GC; Shields JA
Ophthalmology; 2012 Jan; 119(1):188-92. PubMed ID: 21975042
[TBL] [Abstract][Full Text] [Related]
6. Intra-Arterial Chemotherapy for Retinoblastoma: 8-Year Experience from a Tertiary Referral Institute in Thailand.
Rojanaporn D; Chanthanaphak E; Boonyaopas R; Sujirakul T; Hongeng S; Ayudhaya SSN
Asia Pac J Ophthalmol (Phila); 2019; 8(3):211-217. PubMed ID: 30714357
[TBL] [Abstract][Full Text] [Related]
7. Fluorescein angiographic findings after intra-arterial chemotherapy for retinoblastoma.
Bianciotto C; Shields CL; Iturralde JC; Sarici A; Jabbour P; Shields JA
Ophthalmology; 2012 Apr; 119(4):843-9. PubMed ID: 22137042
[TBL] [Abstract][Full Text] [Related]
8. Ophthalmic Vascular Events after Primary Unilateral Intra-arterial Chemotherapy for Retinoblastoma in Early and Recent Eras.
Dalvin LA; Ancona-Lezama D; Lucio-Alvarez JA; Masoomian B; Jabbour P; Shields CL
Ophthalmology; 2018 Nov; 125(11):1803-1811. PubMed ID: 29921454
[TBL] [Abstract][Full Text] [Related]
9. Unilateral Retinoblastoma Managed With Intravenous Chemotherapy Versus Intra-Arterial Chemotherapy. Outcomes Based on the International Classification of Retinoblastoma.
Shields CL; Jorge R; Say EA; Magrath G; Alset A; Caywood E; Leahey AM; Jabbour P; Shields JA
Asia Pac J Ophthalmol (Phila); 2016; 5(2):97-103. PubMed ID: 26765038
[TBL] [Abstract][Full Text] [Related]
10. Management of advanced retinoblastoma with intravenous chemotherapy then intra-arterial chemotherapy as alternative to enucleation.
Shields CL; Kaliki S; Al-Dahmash S; Rojanaporn D; Leahey A; Griffin G; Jabbour P; Shields JA
Retina; 2013; 33(10):2103-9. PubMed ID: 23873161
[TBL] [Abstract][Full Text] [Related]
11. The Addition of Topotecan to Melphalan in the Treatment of Retinoblastoma with Intra-arterial Chemotherapy.
Stacey AW; De Francesco S; Borri M; Hadjistilianou T
Ophthalmol Retina; 2021 Aug; 5(8):824-830. PubMed ID: 33221516
[TBL] [Abstract][Full Text] [Related]
12. Secondary and tertiary intra-arterial chemotherapy for massive persistent or recurrent subretinal retinoblastoma seeds following previous chemotherapy exposure: long-term tumor control and globe salvage in 30 eyes.
Say EA; Iyer PG; Hasanreisoglu M; Lally SE; Jabbour P; Shields JA; Shields CL
J AAPOS; 2016 Aug; 20(4):337-42. PubMed ID: 27328850
[TBL] [Abstract][Full Text] [Related]
13. Comparison between intravenous chemotherapy and intra-arterial chemotherapy for retinoblastoma: a meta-analysis.
Chen Q; Zhang B; Dong Y; Mo X; Zhang L; Huang W; Jiang H; Xia J; Zhang S
BMC Cancer; 2018 Apr; 18(1):486. PubMed ID: 29703164
[TBL] [Abstract][Full Text] [Related]
14. Salvage Intra-arterial Chemotherapy for Recurrent or Persistent Intraocular Retinoblastoma: A Study of 24 Eyes.
Verma R; Adewara BA; Reddy Palkonda VA; Reddy S; Kaliki S
Ophthalmol Retina; 2023 Mar; 7(3):275-281. PubMed ID: 36195261
[TBL] [Abstract][Full Text] [Related]
15. Intra-arterial chemotherapy for retinoblastoma: report No. 1, control of retinal tumors, subretinal seeds, and vitreous seeds.
Shields CL; Bianciotto CG; Jabbour P; Ramasubramanian A; Lally SE; Griffin GC; Rosenwasser R; Shields JA
Arch Ophthalmol; 2011 Nov; 129(11):1399-406. PubMed ID: 21670328
[TBL] [Abstract][Full Text] [Related]
16. OPHTHALMIC VASCULAR EVENTS AFTER INTRA-ARTERIAL CHEMOTHERAPY FOR RETINOBLASTOMA: Real-World Comparison Between Primary and Secondary Treatments.
Ancona-Lezama D; Dalvin LA; Lucio-Alvarez JA; Jabbour P; Shields CL
Retina; 2019 Dec; 39(12):2264-2272. PubMed ID: 30204728
[TBL] [Abstract][Full Text] [Related]
17. Retinoblastoma Control With Primary Intra-arterial Chemotherapy: Outcomes Before and During the Intravitreal Chemotherapy Era.
Shields CL; Alset AE; Say EA; Caywood E; Jabbour P; Shields JA
J Pediatr Ophthalmol Strabismus; 2016 Sep; 53(5):275-84. PubMed ID: 27486728
[TBL] [Abstract][Full Text] [Related]
18. Intra-arterial chemotherapy as primary or secondary treatment for infants diagnosed with advanced retinoblastoma before 3 months of age.
Chen Q; Zhang B; Dong Y; Mo X; Zhang L; Xia J; Zhang J; Zhang S
BMC Cancer; 2019 Jul; 19(1):693. PubMed ID: 31307410
[TBL] [Abstract][Full Text] [Related]
19. Intra-arterial Chemotherapy as Primary Treatment for Cavitary Retinoblastoma: Excellent Response in Eight Tumors.
Zheng Y; Froehler MT; Friedman DL; Daniels AB
Ophthalmol Retina; 2021 May; 5(5):479-485. PubMed ID: 32853834
[TBL] [Abstract][Full Text] [Related]
20. The Efficacy of Alternate Systemic Intravenous Chemotherapy and Intra-arterial Chemotherapy Approach for Eye Globe Salvage in Retinoblastoma.
Han JW; Lee CS; Hahn SM; Ahn WK; Kim HS; Yun H; Lee SC; Kim BM; Kim DJ; Lyu CJ
Cancer Res Treat; 2023 Jan; 55(1):270-278. PubMed ID: 35609621
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]